LIPIXELLE
Live / Registered — Registered — Section 8 accepted (as of 05 Aug 2026)
What this means for you
Registered since 16 Jun 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 16 Jun 2030: the §8 & §9 renewal).
Record
- Serial number
- 88440528
- Registration number
- 6077874
- Mark type
- Word mark
- Filed
- 21 May 2019
- Published for opposition
- 31 Mar 2020
- Registered
- 16 Jun 2020
- Next maintenance filing
- §8 & §9 renewal, due by 16 Jun 2030 (grace period to 16 Dec 2030)
- Attorney of record
- Craig Kuchii, Esq.
Goods and services
- Class 005 — Pharmaceuticals: drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Owner
- Sun Pharma Advanced Research Company Limited, Mumbai, IN
- Sun Pharma Advanced Research Company Limited, Mumbai, IN
- Sun Pharma Advanced Research Company Limited, Mumbai, IN
Prosecution history
- 05 Aug 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 05 Aug 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 04 Aug 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Jun 2026 — TEAS SECTION 8 RECEIVED
- 16 Jun 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 16 Jun 2020 — REGISTERED-PRINCIPAL REGISTER
- 31 Mar 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Mar 2020 — PUBLISHED FOR OPPOSITION
- 11 Mar 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Feb 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Feb 2020 — EXAMINER'S AMENDMENT ENTERED
- 25 Feb 2020 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 25 Feb 2020 — EXAMINERS AMENDMENT E-MAILED
- 25 Feb 2020 — EXAMINERS AMENDMENT -WRITTEN
- 19 Feb 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED